谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Early Response to Eptinezumab Indicates High Likelihood of Continued Response in Patients with Chronic Migraine

Vector Psychometric Group, LLC,Winner Paul K.,Charleston Larry,Hirman Joe,Cady Roger,Brevig Thomas

The Journal of Headache and Pain（2022）

引用 9|浏览19
关键词
Eptinezumab,Chronic migraine,Migraine prevention,Clinical response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要